Pacritinib - CTI BioPharma
At a glance
- Drug Originator S*BIO
- Drug Class Antineoplastics; Aza compounds; Benzene derivatives; Ethers; Macrocyclic compounds; Polycyclic bridged compounds; Pyrimidines; Pyrrolidines; Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Interleukin-1 receptor-associated kinase inhibitors; Janus kinase 2 inhibitors; Macrophage colony-stimulating factor receptor antagonists
- USA Patent Applicants SOBI
- USA Patents 9
- NDAs 1
- International Patents 77
- Patent Applications 3

Disclaimer